Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 92INDUSTRY 54NIH 34NETWORK 26OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Esophageal Neoplasms 7Breast Neoplasms 6Stomach Neoplasms 4Uterine Cervical Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thymoma 1Small Cell Lung Carcinoma 1Recurrence 1Ovarian Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1Fallopian Tube Neoplasms 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1EGFR Positive Non-small Cell Lung Cancer 1Carcinoma, Ovarian Epithelial 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1

Interventions

Gemcitabine 6Cisplatin 5Gefitinib 3Drug Therapy 3Docetaxel 3Radiotherapy 2Pemetrexed 2Paclitaxel 2Oxaliplatin 2Erlotinib Hydrochloride 2olaparib 1Watchful Waiting 1Thoracoscopy 1Thoracic Surgery, Video-Assisted 1Surgical Procedures, Operative 1Sunitinib 1Standard of Care 1Simvastatin 1Robotic Surgical Procedures 1Risk Factors 1Radiation 1Olanzapine 1Nutrition Assessment 1Neoadjuvant Therapy 1Muscle Stretching Exercises 1Irinotecan 1Indocyanine Green 1Fish Oils 1Environmental Biomarkers 1Enteral Nutrition 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Lung Neoplasms × Paclitaxel × Clear all
NCT00686322 2011-09-15

Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)

Taipei Veterans General Hospital, Taiwan

Phase 4 Completed
6 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00453167 2010-07-12

Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer

National Cancer Center, Korea

Phase 2 Completed
35 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡